» Articles » PMID: 34843246

Ex Vivo and In Vivo Evaluation of Dodecaborate-Based Clusters Encapsulated in Ferumoxytol Nanoparticles

Overview
Journal Langmuir
Specialty Chemistry
Date 2021 Nov 29
PMID 34843246
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Host-guest interactions represent a growing research area with recent work demonstrating the ability to chemically manipulate both host molecules as well as guest molecules to vary the type and strength of bonding. Much less is known about the interactions of the guest molecules and hybrid materials containing similar chemical features to typical macrocyclic hosts. This work uses in vitro and in vivo kinetic analyses to investigate the interaction of -dodecahydrododecaborate derivatives with ferumoxytol, an iron oxide nanoparticle with a carboxylated dextran coating. We find that several boron cluster derivatives can become encapsulated into ferumoxytol, and the lack of pH dependence in these interactions suggests that ion pairing, hydrophobic/hydrophilic interaction, and hydrogen bonding are not the driving force for encapsulation in this system. Biodistribution experiments in BALB/c mice show that this system is nontoxic at the reported dosage and demonstrate that encapsulation of dodecaborate-based clusters in ferumoxytol can alter the biodistribution of the guest molecules.

Citing Articles

A small-molecule carrier for the intracellular delivery of a membrane-impermeable protein with retained bioactivity.

Ma X, Zhang Z, Barba-Bon A, Han D, Qi Z, Ge B Proc Natl Acad Sci U S A. 2024; 121(44):e2407515121.

PMID: 39436658 PMC: 11536097. DOI: 10.1073/pnas.2407515121.


Metallacarborane Cluster Anions of the Cobalt Bisdicarbollide-Type as Chaotropic Carriers for Transmembrane and Intracellular Delivery of Cationic Peptides.

Chen Y, Barba-Bon A, Gruner B, Winterhalter M, Aksoyoglu M, Pangeni S J Am Chem Soc. 2023; 145(24):13089-13098.

PMID: 37265356 PMC: 10288510. DOI: 10.1021/jacs.3c01623.

References
1.
Hope M, Hope T, Zhu C, Faraji F, Haraldsson H, Ordovas K . Vascular Imaging With Ferumoxytol as a Contrast Agent. AJR Am J Roentgenol. 2015; 205(3):W366-73. PMC: 5130335. DOI: 10.2214/AJR.15.14534. View

2.
Wang G, Serkova N, Groman E, Scheinman R, Simberg D . Feraheme (Ferumoxytol) Is Recognized by Proinflammatory and Anti-inflammatory Macrophages via Scavenger Receptor Type AI/II. Mol Pharm. 2019; 16(10):4274-4281. PMC: 7513579. DOI: 10.1021/acs.molpharmaceut.9b00632. View

3.
Warneke J, Jenne C, Bernarding J, Azov V, Plaumann M . Evidence for an intrinsic binding force between dodecaborate dianions and receptors with hydrophobic binding pockets. Chem Commun (Camb). 2016; 52(37):6300-3. DOI: 10.1039/c6cc01233g. View

4.
Nakamura H . Boron lipid-based liposomal boron delivery system for neutron capture therapy: recent development and future perspective. Future Med Chem. 2013; 5(6):715-30. DOI: 10.4155/fmc.13.48. View

5.
Kaittanis C, Shaffer T, Ogirala A, Santra S, Perez J, Chiosis G . Environment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching. Nat Commun. 2014; 5:3384. PMC: 4108301. DOI: 10.1038/ncomms4384. View